Payment overview · 2025
General Payments
$120.87
6 reported records · 5 companies
Healthcare provider profile · identity verified
Colin G Bailey, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · LA PLACE, LA · NPI 1740238336
Verified facts
What the public records show
CMS Open Payments records show Colin G Bailey, M.D. received $120.87 in general payments during 2025 across 6 reported records.
Lilly USA, LLC accounted for 31.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 88 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 161 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 112 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 137 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Rybelsus by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 361 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $38.11 | 31.5% | 2 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $30.44 | 25.2% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $23.35 | 19.3% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $15.15 | 12.5% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $13.82 | 11.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $120.87 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $38.11 | 2 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $30.44 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $30.44 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $30.44 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE Normalized: freestyle libre |
Device | Abbott Laboratories | $23.35 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $19.13 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $13.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 161 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
88 | 23 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
161 | 34 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
112 | 25 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
137 | 27 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
361 | 55 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
14 | 14 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1288 | 346 |
| Amlodipine Besylate | Amlodipine Besylate | 960 | 254 |
| Levothyroxine Sodium | Levothyroxine Sodium | 750 | 197 |
| Gabapentin | Gabapentin | 709 | 197 |
| Losartan Potassium | Losartan Potassium | 673 | 170 |
| Pantoprazole Sodium | Pantoprazole Sodium | 546 | 128 |
| Furosemide | Furosemide | 504 | 132 |
| Metformin Hcl | Metformin Hcl | 461 | 125 |
| Carvedilol | Carvedilol | 386 | 99 |
| Metoprolol Succinate | Metoprolol Succinate | 375 | 96 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 364 | 117 |
| Tamsulosin Hcl | Tamsulosin Hcl | 364 | 92 |
| Eliquis | Apixaban | 361 | 55 |
| Lisinopril | Lisinopril | 354 | 91 |
| Alprazolam | Alprazolam | 349 | 75 |
| Potassium Chloride | Potassium Chloride | 346 | 83 |
| Metoprolol Tartrate | Metoprolol Tartrate | 322 | 77 |
| Allopurinol | Allopurinol | 291 | 69 |
| Hydrochlorothiazide | Hydrochlorothiazide | 283 | 82 |
| Escitalopram Oxalate | Escitalopram Oxalate | 279 | 77 |
| Omeprazole | Omeprazole | 277 | 69 |
| Clopidogrel | Clopidogrel Bisulfate | 275 | 70 |
| Fluticasone Propionate | Fluticasone Propionate | 228 | 83 |
| Glimepiride | Glimepiride | 223 | 62 |
| Alendronate Sodium | Alendronate Sodium | 218 | 57 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 214 | 40 |
| Amitriptyline Hcl | Amitriptyline Hcl | 211 | 64 |
| Mirtazapine | Mirtazapine | 206 | 59 |
| Quetiapine Fumarate | Quetiapine Fumarate | 206 | 36 |
| Tramadol Hcl | Tramadol Hcl | 203 | 53 |
| Montelukast Sodium | Montelukast Sodium | 194 | 58 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 181 | 75 |
| Trazodone Hcl | Trazodone Hcl | 178 | 40 |
| Clonazepam | Clonazepam | 168 | 36 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 168 | 55 |
| Clonidine Hcl | Clonidine Hcl | 165 | 45 |
| Donepezil Hcl | Donepezil Hcl | 165 | 48 |
| Mounjaro | Tirzepatide | 161 | 34 |
| Simvastatin | Simvastatin | 161 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 159 | 44 |
| Finasteride | Finasteride | 156 | 36 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 148 | 38 |
| Memantine Hcl | Memantine Hcl | 147 | 26 |
| Xarelto | Rivaroxaban | 145 | 19 |
| Lorazepam | Lorazepam | 142 | 29 |
| Meloxicam | Meloxicam | 138 | 35 |
| Ozempic | Semaglutide | 137 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 135 | 36 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 133 | 35 |
| Nifedipine Er | Nifedipine | 130 | 31 |
| Sertraline Hcl | Sertraline Hcl | 127 | 30 |
| Levetiracetam | Levetiracetam | 126 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 124 | 26 |
| Ezetimibe | Ezetimibe | 123 | 40 |
| Fenofibrate | Fenofibrate | 119 | 30 |
| Oxybutynin Chloride | Oxybutynin Chloride | 119 | 28 |
| Lovastatin | Lovastatin | 118 | 32 |
| Spironolactone | Spironolactone | 115 | 33 |
| Hydralazine Hcl | Hydralazine Hcl | 113 | 34 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 112 | 27 |
| Trulicity | Dulaglutide | 112 | 25 |
| Metformin Hcl Er | Metformin Hcl | 111 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 105 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 105 | 29 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 102 | 19 |
| Sodium Chloride | 0.9 % Sodium Chloride | 102 | suppressed |
| Levemir Flexpen | Insulin Detemir | 100 | 25 |
| Buspirone Hcl | Buspirone Hcl | 99 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 97 | 22 |
| Famotidine | Famotidine | 95 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 93 | 19 |
| Glipizide | Glipizide | 89 | 23 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 88 | 22 |
| Jardiance | Empagliflozin | 88 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 86 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 79 | 19 |
| Januvia | Sitagliptin Phosphate | 78 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 77 | 19 |
| Atenolol | Atenolol | 74 | 20 |
| Novolog Flexpen | Insulin Aspart | 74 | 19 |
| Valsartan | Valsartan | 74 | 19 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 73 | 58 |
| Myrbetriq | Mirabegron | 71 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 70 | 15 |
| Prednisone | Prednisone | 69 | 21 |
| Insulin Aspart Flexpen | Insulin Aspart | 68 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 65 | 28 |
| Tizanidine Hcl | Tizanidine Hcl | 65 | 17 |
| Baclofen | Baclofen | 64 | 11 |
| Meropenem | Meropenem | 64 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 62 | 14 |
| Methocarbamol | Methocarbamol | 62 | 19 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 59 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 59 | 43 |
| Cephalexin | Cephalexin | 58 | 37 |
| Metoclopramide Hcl | Metoclopramide Hcl | 58 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 57 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 57 | 15 |
| Pregabalin | Pregabalin | 57 | 13 |
| Latanoprost | Latanoprost | 56 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 55 | 18 |
| Linzess | Linaclotide | 55 | 12 |
| Levofloxacin | Levofloxacin | 54 | 45 |
| Chlorthalidone | Chlorthalidone | 53 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 53 | 18 |
| Nitroglycerin | Nitroglycerin | 53 | 31 |
| Doxycycline Hyclate | Doxycycline Hyclate | 52 | 37 |
| Tradjenta | Linagliptin | 52 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 51 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 49 | 15 |
| Gemfibrozil | Gemfibrozil | 48 | 13 |
| Warfarin Sodium | Warfarin Sodium | 47 | 11 |
| Rexulti | Brexpiprazole | 46 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 41 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 45 | 16 |
| Mupirocin | Mupirocin | 45 | 31 |
| Dicyclomine Hcl | Dicyclomine Hcl | 44 | 11 |
| Repatha Sureclick | Evolocumab | 44 | suppressed |
| Ketoconazole | Ketoconazole | 43 | 17 |
| Methylprednisolone | Methylprednisolone | 43 | 36 |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Ondansetron Odt | Ondansetron | 42 | 18 |
| Azithromycin | Azithromycin | 41 | 32 |
| Breo Ellipta | Fluticasone/Vilanterol | 41 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 41 | suppressed |
| Glipizide Er | Glipizide | 41 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 41 | 14 |
| Methenamine Hippurate | Methenamine Hippurate | 41 | suppressed |
| Minoxidil | Minoxidil | 40 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 39 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 39 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 38 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 38 | suppressed |
| Diazepam | Diazepam | 37 | suppressed |
| Sucralfate | Sucralfate | 37 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 36 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 36 | 16 |
| Oxcarbazepine | Oxcarbazepine | 36 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 36 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 35 | 11 |
| Lamotrigine | Lamotrigine | 35 | suppressed |
| Nystatin | Nystatin | 35 | 19 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 33 | 15 |
| Risperidone | Risperidone | 33 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 33 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 32 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 32 | suppressed |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 32 | 16 |
| Bumetanide | Bumetanide | 31 | 13 |
| Bupropion Xl | Bupropion Hcl | 30 | suppressed |
| Celecoxib | Celecoxib | 30 | 11 |
| Divalproex Sodium | Divalproex Sodium | 30 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 29 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 28 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 28 | suppressed |
| Naproxen | Naproxen | 28 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 28 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 28 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 27 | suppressed |
| Irbesartan | Irbesartan | 27 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 27 | 22 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 26 | suppressed |
| Rybelsus | Semaglutide | 26 | suppressed |
| Fluconazole | Fluconazole | 25 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 25 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 25 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 24 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Lidocaine | Lidocaine | 24 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 23 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | 13 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Lactulose | Lactulose | 23 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 23 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 22 | 14 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Telmisartan | Telmisartan | 22 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 21 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Metolazone | Metolazone | 20 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Dutasteride | Dutasteride | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Clotrimazole | Clotrimazole | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 17 | suppressed |
| Clonidine | Clonidine | 17 | suppressed |
| Lacosamide | Lacosamide | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Calcium Acetate | Calcium Acetate | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Modafinil | Modafinil | 16 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 16 | suppressed |
| Testosterone | Testosterone | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 15 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 12 |
| Restasis | Cyclosporine | 15 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 15 | 12 |
| Verapamil Sr | Verapamil Hcl | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Ibuprofen | Ibuprofen | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Temazepam | Temazepam | 14 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 14 | suppressed |
| Acetazolamide | Acetazolamide | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Repatha Syringe | Evolocumab | 12 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Fluocinonide | Fluocinonide | 11 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $120.87 · 6 records | Lilly USA, LLC | ABRYSVO, COMIRNATY, Dexcom G6 Transmitter, FREESTYLE LIBRE, MOUNJARO, PREVNAR 20, ZEPBOUND | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error